Related Experiment Video
Updated: Jul 17, 2025
08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
269
A massively parallel approach for assessing CRISPR off-targets in vitro
Shisheng Huang1, Xingxu Huang1,2
1Zhejiang Lab, Hangzhou, Zhejiang 311121, China.
Cell Reports Methods
|September 6, 2023
Summary
Researchers developed AID-seq, a method for identifying CRISPR off-targets in vitro. This approach efficiently screens guide RNA candidates for optimal safety and efficacy in gene editing applications.
Area of Science:
- Molecular Biology
- Gene Editing Technologies
- Biotechnology
Background:
- CRISPR-Cas9 gene editing offers precise DNA modification.
- Off-target effects are a major safety concern for CRISPR applications.
- Efficient screening of guide RNAs (gRNAs) is crucial for minimizing unintended mutations.
Purpose of the Study:
- To introduce AID-seq, a novel method for high-throughput identification of CRISPR nuclease off-targets.
- To enable simultaneous screening of multiple gRNAs for efficiency and safety.
- To facilitate the selection of optimal gRNA candidates for therapeutic gene editing.
Main Methods:
- AID-seq utilizes a pooled strategy for simultaneous analysis.
- The method performs in vitro identification of on- and off-target sites.
- Massively parallel sequencing enables comprehensive gRNA evaluation.
Main Results:
- AID-seq successfully identified off-target mutations for various CRISPR nucleases.
- The pooled strategy allowed for efficient screening of multiple gRNAs.
- The method facilitated the identification of highly efficient and safe gRNA candidates.
Conclusions:
- AID-seq is a powerful tool for evaluating CRISPR gRNA specificity and safety.
- This approach accelerates the development of precise and reliable gene editing tools.
- AID-seq contributes to advancing the safety and efficacy of CRISPR-based therapies.
